Clinical Research
News & Careers
Search the Site
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login           Employers:  Register | Login   

By Industry | By Industry Segment | By Services and Suppliers | By Location | Profile Search
 Company Profile


Isis Pharmaceuticals, Inc. 

Carlsbad Research Center
2292 Faraday Avenue
Carlsbad  California  92008-7208  U.S.A.
Phone: 760-931-9200 Fax: 760-603-4650



 Company News
Isis Pharmaceuticals, Inc. (ISIS) Initiates Phase 1/2 Study Of ISIS-DMPK Rx In Patients With Myotonic Dystrophy Type 1 12/16/2014 8:08:48 AM
Isis Pharmaceuticals, Inc. (ISIS) Reports Positive Phase 2 Data For ISIS-FXI Rx For The Prevention Of Venous Thrombosis In Patients Undergoing Total Knee Replacement Surgery 12/8/2014 7:57:14 AM
Isis Pharmaceuticals, Inc. (ISIS)' CEO, Dr. Stanley Crooke, Receives Prestigious SCRIP Lifetime Achievement Award 12/5/2014 1:23:34 PM
Isis Pharmaceuticals, Inc. (ISIS) Release: ISIS-APOCIII Rx Phase 2 Study In Patients With Familial Chylomicronemia Published In The New England Journal of Medicine 12/4/2014 7:16:46 AM
Isis Pharmaceuticals, Inc. (ISIS) Initiates Phase 3 Study Of ISIS-SMN Rx In Children With Spinal Muscular Atrophy 11/25/2014 9:03:49 AM
Isis Pharmaceuticals, Inc. (ISIS) Release: ISIS-STAT3 Rx And ISIS-AR Rx Data Presented By AstraZeneca PLC (AZN) At European Cancer Symposium 11/21/2014 9:26:05 AM
Genzyme Corporation (GENZ) And Isis Pharmaceuticals, Inc. (ISIS) Present KYNAMRO® Clinical Data At American Heart Association 11/19/2014 12:20:46 PM
Isis Pharmaceuticals, Inc. (ISIS) To Host Webcast To Discuss ISIS-FXI Rx Data Presented At The American Society of Hematology Annual Meeting 11/18/2014 11:43:17 AM
Cure SMA Presents Isis Pharmaceuticals, Inc. (ISIS) With SMA Breakthrough Award 11/17/2014 3:24:31 PM
Isis Pharmaceuticals, Inc. (ISIS) To Present At Upcoming Investor Conferences 11/14/2014 8:05:34 AM